This is a non-core endpoint: only basic statistics are computed.
Other benign neoplasms of uterus (controls excluding all cancers)
CD2_BENIGN_UTERUS_OTH_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule
Sex
only females
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Remove individuals based on genotype QC
1477
CD2_BENIGN_UTERUS_OTH_EXALLC
Control definitions
Control exclude
C3_CANCER
Extra metadata
Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10-D36
Name in latin
Alia neoplasmata benigna uteri
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Other benign neoplasms of uterus (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Other benign neoplasms of uterus
- Benign neoplasms
- Benign neoplasms (controls excluding all cancers)
- Neoplasms
- Any event in hilmo or specialist outpatient
Narrower endpoints:
- Other benign neoplasms of uterus
- Other benign neoplasm of uterus: Other parts/unspecified
- Other benign neoplasm of uterus: Other parts/unspecified (controls excluding all cancers)
- Other benign neoplasm of uterus: Corpus uteri
- Other benign neoplasm of uterus: Corpus uteri (controls excluding all cancers)
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1477 | 1477 | - |
| Unadjusted prevalence (%) | 0.39 | 0.70 | - |
| Mean age at first event (years) | 42.05 | 42.05 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_UTERUS_OTH_EXALLC – Other benign neoplasms of uterus (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Other benign neoplasms of uterus (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.